Drugmaker Cipla has launched Afrezza (insulin human) inhalation powder, the company said, about a year after the product got ...

The insulin inhalation powder in Afrezza is available in single-use cartridges and is delivered via an inhaler device.

Cipla launches Afrezza, an orally inhaled insulin powder for diabetes patients in India. A needle-free alternative to ...

Cipla has launched Afrezza, an inhaled rapid-acting insulin for adults with diabetes, after CDSCO approval, and plans an ...

Manufactured by Connecticut-based biopharmaceutical company MannKind Corporation, Afrezza was first launched in the United ...

Cipla has launched inhaled insulin powder in India, providing a needle-free alternative for diabetes patients. Approved by ...

Cipla had received regulatory approval from the Central Drugs Standard Control Organisation late last year for the exclusive ...

Drug firm Cipla on Monday said it has launched orally inhaled insulin powder for diabetes patients in the country. The company had obtained regulatory approval from the Central Drugs Standard Control ...

Drug prices have continued to rise  despite the exemption of pharmaceutical ingredients from import taxes and duties. This ...

Adherium Ltd. ( ($AU:ADR) ) has provided an update. Adherium has surpassed its key calendar year 2025 shipment targets for its Hailie Smartinhaler ...

Goodblend, located in Austin and San Antonio, previously required patients to place their orders in advance due to limited ...

This viral organization hack is a game-changer, according to plenty of users on TikTok. Here's why you should try the house ...